Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Assisted reproduction vigilance]

G Bréart1, J de Mouzon

  • 1INSERM-U.149, Paris.

Bulletin De L'Academie Nationale De Medecine
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Assisted reproduction techniques (A.R.T.) carry risks like preterm birth and low birthweight. Rigorous evaluation, similar to new drugs, is crucial for A.R.T. safety, including long-term monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

20 years of the European IVF-monitoring Consortium registry: what have we learned? A comparison with registries from two other regions.

Human reproduction (Oxford, England)·2020
Same author

[Propositions for perinatal care at extremely low gestational ages - Working group on "Extremely low gestational ages" for SFMP, CNGOF, and SFN].

Gynecologie, obstetrique, fertilite & senologie·2020
Same author

[Comparative survey of French oocyte donor's profile and motivations between nulliparous and multiparous donors, 2017-2018].

Gynecologie, obstetrique, fertilite & senologie·2020
Same author

[Adverse obstetric and perinatal outcome with in vitro fertilization technology: A French nationwide population-based study].

Gynecologie, obstetrique, fertilite & senologie·2020
Same author

Trends over 15 years in ART in Europe: an analysis of 6 million cycles.

Human reproduction open·2019
Same author

Oocyte and ovarian tissue cryopreservation in European countries: statutory background, practice, storage and use.

Human reproduction open·2019
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Area of Science:

  • Reproductive Medicine
  • Oncology
  • Drug Safety Evaluation

Context:

  • Assisted reproduction outcomes present higher risks of preterm birth, low birthweight, and perinatal mortality compared to the general population.
  • Concerns exist regarding potential links between fertility drug exposure and ovarian cancer risk.
  • The introduction of new assisted reproduction techniques (A.R.T.) necessitates thorough safety and efficacy assessments.

Purpose:

  • To advocate for rigorous evaluation of new assisted reproduction techniques (A.R.T.) comparable to new drug assessments.
  • To emphasize the importance of evaluating both short-term efficacy and safety of A.R.T.
  • To propose a standardized data collection system for A.R.T. centers to enable long-term safety surveillance.

Summary:

Related Experiment Videos

  • Short-term efficacy and safety of new A.R.T. should be assessed using established drug evaluation methodologies.
  • Long-term safety evaluation requires standardized data collection by A.R.T. centers on all attempts and outcomes.
  • Collected data can form the basis for case-control studies investigating the long-term consequences of A.R.T.

    • Impact:

    • Ensures patient safety by proactively identifying and mitigating risks associated with assisted reproduction.
    • Promotes evidence-based practice in reproductive medicine through standardized data collection and analysis.
    • Facilitates a better understanding of the long-term health implications for individuals undergoing assisted reproduction treatments.